[HTML][HTML] Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective …

…, KH Lee, KM Lee, M Takatori, M Nishimura, M Sanui… - Critical care, 2012 - Springer
Introduction Fever is frequently observed in critically ill patients. An independent association
of fever with increased mortality has been observed in non-neurological critically ill patients …

[HTML][HTML] ARDS clinical practice guideline 2021

…, K Ando, T Yoshida, T Masuyama, M Sanui - Journal of intensive …, 2022 - Springer
Background The joint committee of the Japanese Society of Intensive Care Medicine/Japanese
Respiratory Society/Japanese Society of Respiratory Care Medicine on ARDS Clinical …

Metabolic syndrome and acute respiratory distress syndrome in hospitalized patients with COVID-19

…, M Nafa, W Matsuda, R Suzuki, M Sanui… - JAMA network …, 2021 - jamanetwork.com
Importance Obesity, diabetes, and hypertension are common comorbidities in patients with
severe COVID-19, yet little is known about the risk of acute respiratory distress syndrome (…

[HTML][HTML] Safety and efficacy of oral rehydration therapy until 2 h before surgery: a multicenter randomized controlled trial

…, H Yasuda, N Suzuki, H Hinenoya, C Kim, M Sanui… - Journal of …, 2012 - Springer
Purpose In many countries, patients are generally allowed to have clear fluids until 2–3 h
before surgery. In Japan, long preoperative fasting is still common practice. To shorten the …

[HTML][HTML] Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan

…, Y Umemura, M Hayakawa, D Kudo, M Sanui… - Critical Care, 2016 - Springer
Background Little evidence supports anticoagulant therapy as effective adjuvant therapy to
reduce mortality overall in sepsis. However, several studies suggest that anticoagulant …

Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation

…, S Uchino, D Kudo, Y Iizuka, M Sanui… - Thrombosis and …, 2016 - thieme-connect.com
Recombinant human soluble thrombomodulin (rhTM) is a novel class of anticoagulants for
treating disseminated intravascular coagulation (DIC). Although rhTM is widely used in …

[HTML][HTML] The clinical practice guideline for the management of ARDS in Japan

S Hashimoto, M Sanui, M Egi, S Ohshimo… - Journal of intensive …, 2017 - Springer
Background The Japanese Society of Respiratory Care Medicine and the Japanese Society
of Intensive Care Medicine provide here a clinical practice guideline for the management of …

Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems

…, K Yamakawa, D Kudo, Y Iizuka, M Sanui… - Journal of critical …, 2019 - Elsevier
Purpose We investigated the epidemiology and outcome of disseminated intravascular
coagulation (DIC) in patients with sepsis. Materials and methods We analyzed data from a …

Long-term survival in patients with acute kidney injury after acute type A aortic dissection repair

…, H Yasunaga, A Yamaguchi, H Adachi, M Sanui - The Annals of Thoracic …, 2016 - Elsevier
Background Although acute kidney injury (AKI) is known as a serious complication after
operation for acute type A aortic dissection (AAAD), the long-term impact of AKI remains unclear. …

[HTML][HTML] Antithrombin supplementation and mortality in sepsis-induced disseminated intravascular coagulation: a multicenter retrospective observational study

…, S Saito, S Uchino, K Yamakawa, Y Iizuka, M Sanui… - Shock, 2016 - journals.lww.com
Supplemental doses of antithrombin (AT) are widely used to treat sepsis-induced disseminated
intravascular coagulation (DIC) in Japan. However, evidence on the benefits of AT …